No Data
No Data
Raymond James Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $36
H.C. Wainwright Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $55
UroGen Pharma Price Target Cut to $55.00/Share From $64.00 by HC Wainwright & Co.
UroGen Pharma Ltd | 10-K: FY2024 Annual Report
TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $35
Earnings Call Summary | UroGen Pharma Ltd(URGN.US) Q4 2024 Earnings Conference